Polpharma Group is a high quality European pharma manufacturer and a reputable business partner for pharmaceutical companies worldwide. We grow our presence through B2B activities, including API development and manufacturing in our FDA-approved facility, out-licensing of vertically integrated solutions from API to finished formulation, and contract manufacturing services covering a wide variety of solid and liquid forms. With a broad experience in products’ development, manufacturing and marketing, dedicated R&D, Regulatory and Project Management resources, supported by corporate quality system and service excellence, we deliver tailored solutions to meet your business needs.

Polpharma API is a significant European producer of Active Pharmaceutical Ingredients delivering products to pharmaceutical companies worldwide. We are present on 6 continents, in 60+ countries. We provide a one-stop shop solution of vertically integrated services from API development to FDF formulation and manufacturing, scale-up capabilities based on in-house technologies, to regulatory support. At Polpharma quality comes first. Regular FDA audits enabled us to register and sell a number of APIs in the US market and confirm our reliability and credibility towards our business partners around the world. 

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Meet us at

CPHI Middle East & Africa 2021

RICEC, Riyadh, Saudi Arabia

26-28 September 2021

Book a meeting
View Our Exhibitor Profile

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info